Anatomical predictors of conduction damage after transcatheter implantation of the aortic valve.

heart block left bundle branch block permanent pacemaker implantation transcatheter aortic valve implantation transcatheter aortic valve replacement

Journal

Open heart
ISSN: 2053-3624
Titre abrégé: Open Heart
Pays: England
ID NLM: 101631219

Informations de publication

Date de publication:
Historique:
received: 19 11 2018
revised: 20 02 2019
accepted: 04 03 2019
entrez: 7 6 2019
pubmed: 7 6 2019
medline: 7 6 2019
Statut: epublish

Résumé

Conduction damage following transcatheter aortic valve implantation (TAVI) remains common. Anatomical risk factors remain elusive. We assessed the impact of variability in the dimensions of the membranous septum and position of the aortic root on the occurrence of conduction damage following TAVI. The dimensions of the membranous septum, the rotational position of the aortic root correlating to variability in the central fibrous body width, and wedging of the aortic root were assessed on pre-TAVI CT datasets. The depth of implantation was measured from the final aortic angiogram. The variables were compared with the occurrence of both permanent pacemaker insertion (PPI) and left bundle branch block (LBBB) following TAVI. Of 200 patients who met inclusion criteria (mean age = 81 years ± 7.7, 49% men), 20.5 % underwent PPI after TAVI. New LBBB occurred in 23.5%, 21.3 % of whom required PPI. Preprocedural right bundle branch block (OR = 7.00; CI 3.13 to 15.64), valve type (OR=2.35; CI 1.13 to 4.87), depth of implantation (OR=1.62; CI 1.01 to 2.61) and the difference between depth of implantation and the distance from the virtual basal ring to the inferior margin of the membranous septum (OR=0.61; CI 0.38 to 0.99) were all associated with PPI, with similar associations with LBBB. No gross anatomical variable alone was associated with conduction damage. Gross anatomical variation of the aortic root and its underlying support, including the membranous septum, were not associated with the occurrence of either PPI or new LBBB. Procedural characteristics associated with these adverse outcomes suggest that the depth of implantation and radial force of the bioprosthesis, regardless of gross anatomical variability, increase the risk for conduction damage.

Identifiants

pubmed: 31168378
doi: 10.1136/openhrt-2018-000972
pii: openhrt-2018-000972
pmc: PMC6519402
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e000972

Déclaration de conflit d'intérêts

Competing interests: DJK is on the scientific advisory board for and a consultant for Boston Scientific Corporation.

Références

Circ Cardiovasc Interv. 2008 Aug;1(1):74-81
pubmed: 20031657
J Cardiovasc Comput Tomogr. 2012 Nov-Dec;6(6):366-80
pubmed: 23217460
Int J Cardiol. 2014 Jun 1;174(1):1-6
pubmed: 24750717
J Am Coll Cardiol. 2014 Jul 15;64(2):129-40
pubmed: 25011716
JACC Cardiovasc Interv. 2015 Aug 17;8(9):1218-1228
pubmed: 26292585
Circ J. 2016;80(1):24-33
pubmed: 26673171
JACC Cardiovasc Interv. 2016 Feb 8;9(3):244-254
pubmed: 26847116
N Engl J Med. 2016 Apr 28;374(17):1609-20
pubmed: 27040324
J Am Soc Echocardiogr. 2016 Dec;29(12):1131-1143
pubmed: 27742239
JACC Cardiovasc Interv. 2016 Nov 14;9(21):2189-2199
pubmed: 27832844
JACC Cardiovasc Interv. 2016 Nov 14;9(21):2200-2209
pubmed: 27832845
N Engl J Med. 2017 Apr 6;376(14):1321-1331
pubmed: 28304219
J Am Coll Cardiol. 2017 Jul 11;70(2):252-289
pubmed: 28315732
J Anat. 2017 Jul;231(1):110-120
pubmed: 28397961
JACC Cardiovasc Imaging. 2017 Oct;10(10 Pt A):1139-1147
pubmed: 28412434
J Invasive Cardiol. 2017 May;29(5):181-186
pubmed: 28441641
Circulation. 2017 Sep 12;136(11):1049-1069
pubmed: 28893961
Heart. 2018 Jun;104(12):999-1005
pubmed: 29146623
JAMA. 2018 Jan 2;319(1):27-37
pubmed: 29297076
Circ Cardiovasc Interv. 2018 Feb;11(2):e005344
pubmed: 29386188
JACC Cardiovasc Interv. 2018 Feb 12;11(3):301-310
pubmed: 29413244
Eur Heart J. 2018 Jun 1;39(21):2003-2013
pubmed: 29420704
Clin Anat. 2018 May;31(4):525-534
pubmed: 29542191

Auteurs

Justin T Tretter (JT)

Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

Shumpei Mori (S)

Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.

Robert H Anderson (RH)

Institute of Genetic Medicine, Newcastle University, Newcastle-upon-Tyne, UK.

Michael D Taylor (MD)

Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

Nicholas Ollberding (N)

Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

Vien Truong (V)

Department of Ohio Heart and Vascular, The Christ Hospital and Lindner Center for Research and Education, Cincinnati, Ohio, USA.

Joseph Choo (J)

Department of Ohio Heart and Vascular, The Christ Hospital and Lindner Center for Research and Education, Cincinnati, Ohio, USA.

Dean Kereiakes (D)

Department of Ohio Heart and Vascular, The Christ Hospital and Lindner Center for Research and Education, Cincinnati, Ohio, USA.

Wojciech Mazur (W)

Department of Ohio Heart and Vascular, The Christ Hospital and Lindner Center for Research and Education, Cincinnati, Ohio, USA.

Classifications MeSH